Researchers are excited about Retatrutide , a novel dual agonist showing promising results in early trials for weight reduction . It functions by modulating two pathways : GLP-1 and GIP, which , when https://rsamigc726098.blogdal.com/41192435/this-new-possibility-for-size-reduction